Literature DB >> 23701650

Gilbert's syndrome and the risk of death: a population-based cohort study.

Laura J Horsfall1, Irwin Nazareth, Stephen P Pereira, Irene Petersen.   

Abstract

BACKGROUND AND AIMS: Gilbert's syndrome is a common familial hyperbilirubinemia that may reduce the risk of various age-related diseases because of the antioxidant properties of bilirubin. We conducted a large cohort study using The Health Improvement Network primary care database and compared all-cause mortality rates in those with and without Gilbert's syndrome.
METHODS: Mortality rates in patients with a diagnosis of Gilbert's syndrome and raised bilirubin level (n = 4266) were compared with those of patients with similar characteristics but with normal bilirubin levels (n = 21 968). Multivariate Poisson regression was also used to estimate adjusted mortality rate ratios.
RESULTS: During the 350 000 PYs of follow up across the Gilbert's and comparison cohorts, there were 1174 deaths. Mortality rates were 24/10 000 PYs in the Gilbert's cohort versus 50/10 000 PYs in the comparison cohort. Mortality rates were around half in patients with Gilbert's syndrome after accounting for sociodemographics and general health indicators (adjusted mortality rate ratio: 0.5 [95% confidence interval; 0.4-0.7; P < 0.001]).
CONCLUSIONS: Mortality rates observed for people with Gilbert's syndrome in the general population are almost half those of people without evidence of Gilbert's syndrome.
© 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Gilbert disease; bilirubin; bilirubin uridine-diphosphoglucuronosyl transferase 1A1; cohort; database; mortality

Mesh:

Substances:

Year:  2013        PMID: 23701650     DOI: 10.1111/jgh.12279

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  17 in total

1.  Pregnancy with gilbert syndrome - a case report.

Authors:  Mini Mohan; Lakshmi Sailaja P; Peddireddy Vijaya Narasimha Reddy
Journal:  J Clin Diagn Res       Date:  2014-06-20

2.  Evaluating elevated bilirubin levels in asymptomatic adults.

Authors:  Lisa B VanWagner; Richard M Green
Journal:  JAMA       Date:  2015-02-03       Impact factor: 56.272

3.  Gilbert's syndrome in healthy blood donors what next??

Authors:  Rajendra G Kulkarni; K B Lakshmidevi; Vidya Ronghe; U S Dinesh
Journal:  Asian J Transfus Sci       Date:  2016 Jan-Jun

4.  Longer telomeres in chronic, moderate, unconjugated hyperbilirubinaemia: insights from a human study on Gilbert's Syndrome.

Authors:  Anela Tosevska; Christine Moelzer; Marlies Wallner; Milan Janosec; Ursula Schwarz; Carina Kern; Rodrig Marculescu; Daniel Doberer; Wolfram Weckwerth; Karl-Heinz Wagner
Journal:  Sci Rep       Date:  2016-03-01       Impact factor: 4.379

5.  Elevated bilirubin levels are associated with a better renal prognosis and ameliorate kidney fibrosis.

Authors:  Sehoon Park; Do Hyoung Kim; Jin Ho Hwang; Yong-Chul Kim; Jin Hyuk Kim; Chun Soo Lim; Yon Su Kim; Seung Hee Yang; Jung Pyo Lee
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

6.  Cardiovascular outcomes among HIV-infected veterans receiving atazanavir.

Authors:  Joanne LaFleur; Adam P Bress; Lisa Rosenblatt; Jacob Crook; Paul E Sax; Joel Myers; Corey Ritchings
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

7.  Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II.

Authors:  Lei Sun; Man Li; Liang Zhang; Xiaoying Teng; Xiangmei Chen; Xingang Zhou; Zhiyuan Ma; Liming Qi; Peng Wang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

Review 8.  Suppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone Metastases.

Authors:  Mark F McCarty; James DiNicolantonio
Journal:  Healthcare (Basel)       Date:  2016-08-25

Review 9.  Atazanavir and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Patients: A Systematic Review.

Authors:  Dominic Chow; Cecilia Shikuma; Corey Ritchings; Muxing Guo; Lisa Rosenblatt
Journal:  Infect Dis Ther       Date:  2016-09-27

10.  Antioxidant bilirubin works in multiple ways to reduce risk for obesity and its health complications.

Authors:  James J DiNicolantonio; Mark F McCarty; James H O'Keefe
Journal:  Open Heart       Date:  2018-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.